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CASE REPORTSuccessful management of post-TIPSS
encephalopathy with a balloon-expandable
covered stent: a controllable method to reduce
shunt flow
K. Karuppasamy*, A.E. Healey, J.C. EvansDepartment of Radiology, Royal Liverpool University Hospital, Liverpool, UKIntroduction
Transjugular intrahepatic portosystemic shunt
(TIPSS) is recognized as a useful technique in
cases that fail to respond to two endoscopic
sessions after acute variceal bleeds.1 TIPSS has
been shown to be as effective in managing acute
gastric bleeds as in managing acute oesophageal
bleeds.2 The major complications of TIPSS pro-
cedures are shunt insufficiency and hepatic ence-
phalopathy.1 New or worsened hepatic
encephalopathy after TIPSS has been seen in up to
35% of cases, and it has been reported to be
refractory to conservative medical treatment in up
to 7% of cases,3,4 in whom further intervention has
been necessary to reduce flow through the TIPSS.
This may be performed by occluding the shunt
completely or by using one of a variety of
endovascular devices aimed at reducing the calibre
of the stent lumen,5 which increases the portosys-
temic pressure gradient across the stent and
improves intrahepatic portal bloodflow. Such tech-
niques often improve the encephalopathy, but they
may increase the risk of variceal bleeding, requiring
a fine balance between the two.
In this article, we describe a method to increase
the portosystemic pressure gradient across the
shunt in a controllable way, thus reducing ence-
phalopathy but also minimizing the risks of further
bleeding.1477-6804/$ - see front matter Q 2005 The Royal College of Radiolo
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A 69-year-old Caucasian man, known to have
alcoholic liver disease, cirrhosis and oesophageal
varices, was admitted with dizziness and a 2-week
history of dark stools. On admission the haemo-
globin (Hb) was 6.8 g/dl but liver function tests
(LFTs) were normal. Upper gastrointestinal (GI)
endoscopy showed three polypoid lesions in the
antrum and a varix in the fundus with a red nipple
on it, indicating recent bleeding. After transfusing 4
units of blood, the man’s Hb increased to 11.1 g/dl.
His gastric bleeding was considered to be due to the
high dose of beta-blocker he was taking, and hence
the dose was halved. Since his general condition
improved without any further dizzy spells, he was
discharged after 9 days in hospital.
Upper GI endoscopy performed at elective
follow-up 2 weeks after discharge demonstrated
fresh blood in the stomach from the antral polyp
and varices in the fundus. The Hb at this time was
6.1 g/dl and LFTs remained normal. After another 4
units of blood transfusion, the Hb increased to
8.7 g/dl. A repeat upper GI endoscopy 1 week after
admission, showed fresh clot in the fundus of the
stomach and oozing from fundal and antral polypoid
erosions. The next day, a mesenteric angiogram
was performed; it showed varices of the short
gastric veins and marked splenorenal shunting. The
patient underwent a TIPSS procedure immediately,
with insertion of a Wallstent (Boston Scientific
Ireland, Galway, Eire), 9.4 cm long and 10 mm in
diameter, which was ballooned to 10 mm. The
varices were still widely patent after stenting, and
were therefore embolized with multiple coils
(William Cook Europe, Bjaeverskov, Denmark).Clinical Radiology Extra (2005) 60, 60–63gists. Published by Elsevier Ltd. All rights reserved.
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and the procedure was completed without
complication.
A week after discharge, the man was admitted
with grade 1 encephalopathy. As he improved
clinically with an increasing dosage of lactulose,
he was discharged after 4 days. Within 2 days of
discharge he returned, with mounting confusion. CT
of the brain ruled out intracranial bleeding or
infarction. From grade 1 encephalopathy, his
condition worsened to grade 3 encephalopathy
within 6 days of admission.
A shuntogram was performed via the left internal
jugular vein after US demonstrated thrombus
completely filling the right internal jugular vein. A
0.35–3-mm J-wire was passed into the inferior vena
cava. The tip of a 12 French TIPSS sheath was
placed at the confluence of the hepatic veins. A C1
catheter (Cordis Europa N.V., Netherlands) and
0.35 hydrophilic wire (Terumo Corporation, Tokyo,
Japan) were used to cross the stent and enter the
portal vein. There was no pressure gradient across
the stent. Contrast injections demonstrated closure
of the previously dilated and coiled gastric varices
and rapid flow of contrast through the shunt into
the systemic venous circulation via the TIPSS stent.
In order to create a pressure gradient across the
stent and reduce the encephalopathy, the decision
was made to reduce the calibre of the stent.Figure 1 Initial portal venogram showing minimal
intrahepatic portal venous bloodflow and a patent TIPSS
stent. The portosystemic gradient was zero.Technique
Before surgery, a balloon-mountable JOSTENT
(Abbott Laboratories, Maidenhead, UK), 6 to
12 mm in calibre, 38 mm long and covered with
polytetrafluroethylene (PTFE), was selected; a 10-
mm angioplasty balloon was inflated several times
and roughened using an alcohol swab (Steret, Seton
Health Care Group, Oldham, UK). The JOSTENT was
then securely mounted on the balloon. The sheath
was positioned with its tip within the intra-
abdominal TIPSS stent and the 0.35 hydrophilic
wire was replaced with a stiff Amplatz wire (Boston
Scientific, Miami, USA). The new covered stent was
advanced on its balloon mount until approximately
1 cm of its distal end was outside the sheath. The
balloon was then inflated to expand only the distal
portion (leading end) of the JOSTENT to 10 mm and
allow it to gain good purchase against the inside of
the existing TIPSS stent. The balloon was deflated
and withdrawn so that it lay within the proximal
1 cm of the JOSTENT. The sheath was then with-
drawn to allow inflation of the balloon within the
proximal part of the JOSTENT, creating an hourglass
configuration. Concern had been raised that theJOSTENT might become tightly engaged with the
inside of the sheath after initial balloon inflation. If
this had occurred, the balloon could have been used
to anchor the distal end of the stent and provide
counter-traction while the sheath was retracted.
The new portosystemic pressure gradient across
the stent was 21 mmHg. The undilated central
portion of the JOSTENT was still only 12 F; there-
fore, to reduce the gradient across the stent, this
central portion was serially dilated to a final
diameter of 6 mm. This resulted in an acceptable
pressure gradient of 8 mmHg.
There were no immediate complications. The
man was returned to a general ward for standard
post-procedure nursing care. He experienced rapid
resolution of the encephalopathy and had no
further episodes of gastrointestinal haemorrhage.
Following this, his clinical state steadily pro-
gressed. On review in the outpatients department 7
months after discharge, he was well, with no
evidence of encephalopathy. There has been no
further episode of GI bleeding to date. Doppler US
showed a patent TIPSS stent and normal direction of
bloodflow in the portal vein (Figs. 1–3).Discussion
The main drawbacks of TIPSS are shunt insufficiency
and worsening encephalopathy or development of
new encephalopathy. In up to 60% of cases, shunt
stenosis can be expected as a result of pseudo-
intimal hyperplasia, warranting regular shunt sur-
veillance. Hepatic encephalopathy which develops
as a result of portosystemic shunting and poor
Figure 2 A balloon-mounted covered JOSTENT was
advanced until 1 cm of its distal (leading) end was outside
the sheath, and the balloon was inflated to expand only
the distal portion of the stent to 12 mm.
Figure 3 The balloon after deflation was withdrawn to
lie within the proximal 1 cm of the covered stent, and the
sheath was withdrawn to allow inflation of the proximal
part of the stent, creating an hourglass configuration.
This was followed by serial dilatation of the central,
initially undilated portion of the 12 F stent to 6 mm. This
resulted in an acceptable pressure gradient of 8 mmHg.
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the follow-up of approximately 35% of cases
managed with TIPSS, compared with 20% of those
managed only endoscopically.1 Therefore,
measures taken to effectively manage post-TIPSS
encephalopathy would improve the morbidity and
might reduce the encephalopathy-related mortality
among these patients. Several reports have
described life-threatening effects, due to sudden,
severe haemodynamic alterations, when perma-
nent shunt occlusion was used to manage post-TIPSS
encephalopathy.5 However, TIPSS occlusion by
intentional thrombosis can have the advantage of
reversibility if need arises; like a variceal bleed, it
carries the risks associated with sudden occlusion
and thrombus propagation. Techniques using
uncovered constrained stents faced the difficulty
of accurately regulating bloodflow across stents and
inability to immediately measure the pressure
gradient. Use of constrained covered stents has
the advantage of reducing the shunt lumen, with an
immediate measurable increase in the portosyste-
mic gradient. Polyethyleneterephthalate-covered
stents carry the risk of earlier shunt occlusion due
to thrombogenic response to the material, and
PTFE stent grafts may be superior in this situation.5
There has been only one earlier report of a PTFE-
covered balloon-expandable JOSTENT graft used inthe successful management of post-TIPSS hepatic
encephalopathy.6 The technique, which we have
used, is grossly the same as that reported pre-
viously, but there are some differences. By rough-
ening the surface of the balloon, we believe that
any potential loosening between the JOSTENT and
its balloon mount during the procedure can be
avoided; we achieved this by inflating the balloon
several times immediately before surgery and
rubbing its surface with an alcohol swab. The distal
(leading) end of the JOSTENT can be inflated after
either advancing the stent with its balloon mount
until approximately 1 cm of this complex lies
outside the sheath (as we have described), or
withdrawing the sheath and exposing only the distal
1 cm of the JOSTENT and its balloon mount (as
described in the previous report). In our technique,
after the JOSTENT was refashioned into an hour-
glass shape within the existing TIPSS stent, the
portosystemic pressure gradient was still high. In an
effort to avoid total loss of this pressure gradient by
overdilatation of the waist of the JOSTENT, serial
pressure measurements across the JOSTENT and
graduated balloon expansion of the JOSTENT waist
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factory portosystemic pressure gradient was
achieved. This part of the technique was not
described in the previous report.
This method was successful in the management
of post-TIPSS encephalopathy, with total neuro-
logical resolution of the condition. Before the TIPSS
reduction was undertaken, the loss of a pressure
gradient across the stent over a period of time
could have resulted in the loss of hepatic sinusoidal
perfusion. The change in haemodynamic effect
across the hourglass stricture created in the new
stent restored sinusoidal perfusion, resulting in
resolution of the encephalopathy.7 The opportunity
to perform serial pressure gradient measurements
across the new stent, and then serial expansions of
the central portion of the hourglass stent, allowed
precise control of the resulting pressure gradient.
To our knowledge, this element of controllability
has never previously been reported. The long-term
effect of our TIPSS reduction technique in the
overall management of the case is yet to be
established.Conclusion
The technique we used to intentionally constrict
the TIPSS lumen to a desirable diameter by using a
balloon-expandable covered stent, inflated only at
its ends, restored the portosystemic gradientpressure. This increased the intrahepatic portove-
nous flow and successfully resolved the TIPSS-
induced encephalopathy. This technique could
now be considered in the management of refractory
post-TIPSS encephalopathy.References
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